Life insurance with cardiomyopathy is absolutely possible—but approvals and pricing depend on the type of cardiomyopathy, how stable the condition has been, and what your most recent cardiac testing shows. Many people assume cardiomyopathy equals an automatic decline. In reality, the outcome usually comes down to how the carrier interprets your overall heart function, your risk of progression, and whether there have been complications like arrhythmias, hospitalizations, or heart failure symptoms.

At Diversified Insurance Brokers, we specialize in high-risk life insurance cases involving heart disease, complex diagnoses, and prior declines. We work with a nationwide network of 100+ top-rated carriers and help clients position their medical history correctly from the start—so underwriting sees a clear, accurate, well-documented profile instead of guessing. If you’ve already been declined, rated higher than expected, or told your case is “too risky,” our job is to identify what triggered that decision and approach carriers that are more realistic for your situation.

Cardiomyopathy isn’t one diagnosis—it’s a broad category that can range from mild, stable, and well-managed to more advanced and highly monitored. That’s exactly why the same word on two applications can produce very different offers. Some applicants still qualify for traditional term life insurance and select permanent policies, while others may need more specialized options. The key is understanding where your case falls before an application gets submitted the wrong way.

How Cardiomyopathy Is Evaluated for Life Insurance

Life insurance companies underwrite cardiomyopathy with deeper scrutiny than many applicants expect because it can impact long-term heart function and early claim risk. Underwriters don’t just ask, “Do you have cardiomyopathy?” They want to know how the condition affects your heart’s performance over time, how stable it has been, and whether it has created risk events like arrhythmias, heart failure symptoms, or recurrent emergency care.

From an underwriting perspective, cardiomyopathy is usually evaluated using a combination of clinical diagnosis details, objective cardiac testing, and stability patterns. This is why some applicants are approved at manageable ratings while others may be postponed or limited to non-traditional options. Underwriters care less about the name of the condition and more about what it has done and what it appears likely to do going forward.

If you’re also navigating other health issues that can compound cardiac risk (like diabetes, sleep apnea, COPD, or prior heart events), it can help to review our broader guide on life insurance with pre-existing conditions, since many carriers evaluate the total risk picture—not one diagnosis in isolation.

Types of Cardiomyopathy (Why the “Type” Matters)

Cardiomyopathy includes several different conditions that carriers treat very differently. The type helps underwriting estimate how predictable the disease is, what complications are most likely, and what the long-term stability outlook looks like.

Most carriers categorize cardiomyopathy into a few broad buckets such as:

• Dilated cardiomyopathy (DCM) — often evaluated closely for EF, heart failure symptoms, and progression risk
• Hypertrophic cardiomyopathy (HCM) — often reviewed for family history, obstruction, arrhythmias, and activity restrictions
• Restrictive cardiomyopathy — typically reviewed conservatively due to functional limitations and systemic associations
• Arrhythmogenic right ventricular cardiomyopathy (ARVC/ARVD) — underwritten with strong focus on arrhythmia risk and device history

Underwriters also try to determine whether the cardiomyopathy is linked to a known underlying cause, such as hypertension, coronary disease, viral myocarditis, alcohol-related heart muscle damage, chemotherapy history, or genetic background. These details can materially shift underwriting decisions.

The Single Most Important Number: Ejection Fraction (EF)

One of the most important metrics underwriters review is left ventricular ejection fraction (EF). EF is a measurement of how effectively the heart pumps blood. It’s not the only factor, but it’s one of the strongest “snapshot” indicators carriers use to assess severity and stability.

From a practical standpoint, carriers typically want to see:

• Recent EF testing (often within the last 6–12 months depending on the carrier)
• Stability over time (multiple EF readings that show consistency rather than decline)
• Supportive cardiology notes describing symptoms as controlled and management as stable

EF is often interpreted alongside echocardiograms, stress tests, Holter monitoring, and any history of arrhythmias or hospitalization. A stable EF with consistent follow-up can move a case into a more insurable tier than many people expect—especially when there are no recent acute cardiac events.

Symptoms, Stability, and Daily Functioning

Beyond test results, carriers evaluate how cardiomyopathy affects daily life. Underwriters pay close attention to symptoms because symptoms tell the story of how the condition functions in real life—not just on paper. Symptoms like shortness of breath with minimal activity, dizziness, fainting, chest pain, or worsening fatigue can raise concerns about progression and future risk.

Applicants often underwrite best when records show:

• Minimal or controlled symptoms
• No recent ER visits or urgent cardiac events
• Stable medication regimen without frequent escalation
• Regular cardiology follow-ups and documented compliance

Stability matters as much as severity. A moderately reduced EF that has remained consistent for years with stable notes may underwrite better than a slightly better EF that is declining rapidly or paired with recurrent hospital visits.

Medications and Devices (Pacemakers / ICDs)

Cardiomyopathy often involves cardiac medications, and medication use by itself is not a disqualifier. Underwriters usually interpret medications as a signal of management—and the real question becomes whether the treatment plan is working.

Many cardiomyopathy cases involve implanted devices such as pacemakers or an implantable cardioverter defibrillator (ICD). Having an ICD does not automatically mean you cannot get coverage, but it typically changes the underwriting lens. Carriers will often focus on the reason it was implanted, whether there have been shocks, what the underlying rhythm history looks like, and what cardiology notes show regarding stability.

Because device and rhythm history can get technical fast, some applicants benefit from reviewing related cardiac underwriting topics as well—especially if the file involves conduction issues or rhythm abnormalities that overlap with cardiomyopathy risk.

Who Life Insurance with Cardiomyopathy Is Best Suited For

Life insurance after a cardiomyopathy diagnosis is often most achievable when the condition is stable, well monitored, and supported by clear, up-to-date test results. This usually includes applicants who have:

• Consistent cardiology care and documented follow-up
• No recent heart failure admissions
• Stable or improving EF readings
• Minimal or controlled symptoms
• No recent major rhythm emergencies

We also frequently help people who have been declined elsewhere. Many of those declines happen because the case was submitted without full context, or it was sent to a carrier that takes an overly conservative stance on cardiac risk. When you approach the right carriers with the right documentation, outcomes can look very different.

What Improves Underwriting Outcomes

When we help clients improve the probability of an approval (and avoid unnecessary declines), we focus on the underwriting drivers that consistently move cases into better categories. The biggest improvements usually come from documenting stability and removing uncertainty.

In many cardiomyopathy cases, the strongest factors include:

• Stable EF over time (not just one reading)
• No recent acute events (ER visits, admissions, heart failure exacerbations)
• Clear cardiology follow-up with documented compliance
• Non-smoker profile and clean tobacco history
• Controlled blood pressure and cholesterol (especially when cardiomyopathy is not progressive)

Organization matters too. A clean, well-presented medical file helps underwriting move faster and reduces the chance the carrier defaults to conservative assumptions.

Typical Policy Outcomes We See

There is no “standard” result for cardiomyopathy because the condition spans such a wide range of severity. That said, there are patterns that show up repeatedly in underwriting.

For milder and stable cases, traditional term life insurance or permanent policies may be available—sometimes at standard rates, but more often at mild-to-moderate table ratings depending on the file. For moderate cardiomyopathy cases, it’s common to see table-rated offers that still provide meaningful protection at a workable premium.

For more advanced or unstable cases, carriers may postpone, decline, or require more time and documentation. In those situations, we may explore alternative options such as simplified issue, guaranteed issue, or graded benefit coverage so you still have protection while you work toward future insurability.

No two cardiomyopathy cases are identical. Our role is to match your specific medical profile with carriers most likely to interpret your stability favorably.

Why Work With Diversified Insurance Brokers

Cardiac underwriting is one of the most technical areas of life insurance. Many agents submit cardiomyopathy cases to one carrier, get a decline, and stop. That approach fails clients—especially when there are carriers in the market that may still consider the file with the right presentation.

At Diversified Insurance Brokers, we pre-screen cardiomyopathy cases, identify carrier fit, and control how the medical history is presented. This helps avoid unnecessary declines and protects future options. Because we’re independent and work with 100+ top-rated insurers, we’re not limited to a single underwriting philosophy.

Our clients benefit from a confidential, streamlined approach—where we focus on realistic outcomes, clean underwriting strategy, and a coverage plan that actually fits the reason you’re buying life insurance in the first place.

Example Case

A 60-year-old non-smoker with dilated cardiomyopathy and an ejection fraction of 45% came to us after being declined by two insurers. He had no recent hospitalizations and consistent cardiology follow-ups. By positioning his case with a carrier known for flexibility in moderate cardiac profiles, we secured a $250,000 10-year term policy at a manageable table rating—saving him more than $600 per year compared to prior offers.